DAX22.038 +0,6%ESt505.391 +0,6%Top 10 Crypto14,77 +1,8%Dow44.509 +0,1%Nas19.671 -0,2%Bitcoin92.334 -2,3%Euro1,0345 +0,4%Öl76,99 +1,1%Gold2.906 ±-0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 TUI TUAG50 Tesla A1CX3T Palantir A2QA4J Rheinmetall 703000 BYD A0M4W9 Deutsche Telekom 555750 RENK RENK73 Siemens Energy ENER6Y Super Micro Computer A40MRM Xiaomi A2JNY1 Allianz 840400 BASF BASF11 Bayer BAY001 Amazon 906866
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX schließt über 22.000 Punkten -- Dow kaum bewegt -- Merck bestätigt Springworks-Gespräche -- TUI setzt in Q1 mehr um -- KNDS wird neuer Haupteigner von RENK -- VW, Lyft im Fokus
Top News
Deutsche Börse-Aktie: Rekordergebnis und Dividendenerhöhung - Aktienrückkaufprogramm beschlossen Deutsche Börse-Aktie: Rekordergebnis und Dividendenerhöhung - Aktienrückkaufprogramm beschlossen
Börse New York: Dow Jones am Dienstagnachmittag auf grünem Terrain Börse New York: Dow Jones am Dienstagnachmittag auf grünem Terrain
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Telix Pharmaceuticals Aktie

NeuKaufenVerkaufen
17,20 EUR ±0,00 EUR ±0,00 %
FSE
17,80 USD -0,26 USD -1,44 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Bei einem anderen Broker handelnSmartphone

Marktkap.5,90 Mrd. EUR

WKNA40FCQ

ISINUS87961M1053

SymbolTLX

Telix Pharmaceuticals Aktien News

DatumMeistgelesen
PR NewswireIlluccix® Approved in Denmark
PR NewswireTelix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
PR NewswireTelix Completes Acquisition of RLS (USA) Inc.
PR NewswireImaginAb, Inc. Innovative Biologics-Technologieplattform von Telix erworben, um die Entdeckung von therapeutischen Wirkstoffen der nächsten Generation zu ermöglichen
PR NewswireImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery
PR NewswireImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery
PR NewswireIlluccix® Receives European Approval
PR NewswireIlluccix® Receives European Approval
PR NewswireTelix Presentation to the 43rd Annual J.P. Morgan Healthcare Conference
PR NewswireTelix Exceeds FY24 Guidance with US$142M Q4 Revenue
PR NewswireScintimun® Commercialization Partnership with Curium Pharma
PR NewswireScintimun® Commercialization Partnership with Curium Pharma
PR NewswireTelix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
PR NewswireTelix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
PR NewswireNOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports
PR NewswireNOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports
PR NewswireTelix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging
PR NewswireTelix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete
PR NewswireTelix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete
PR NewswireFirst Patient Dosed in Phase III ZIRCON-CP Trial of TLX250-CDx for Kidney Cancer Imaging in Chinese Patients
PR NewswireTelix to Add FAP-Targeting Candidates to Theranostic Pipeline
PR NewswireTelix to Add FAP-Targeting Candidates to Theranostic Pipeline
PR NewswireTelix and Eckert & Ziegler to Partner on Actinium-225 Production Technology
PR NewswireTelix Welcomes CMS Decision to Improve Payments for Diagnostic Radiopharmaceuticals
PR NewswireTelix Partners with Subtle Medical on AI-Enabled SubtlePET™ Software for Faster PET Imaging with Illuccix®
PR NewswireTelix Partners with Subtle Medical on AI-Enabled SubtlePET™ Software for Faster PET Imaging with Illuccix®
PR NewswireFDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
PR NewswireTelix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals
PR NewswireTelix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals
PR NewswireTelix Files Form 20-F Registration Statement for Nasdaq ADS
PR NewswireTelix Q3 2024 Business Update - Quarterly Revenue Exceeds AU$200M
PR NewswireTelix Featured in 13 Abstracts at the Annual Congress of the European Association of Nuclear Medicine (EANM)
PR NewswireAustralian TGA Approves Additional Indication for Telix's Illuccix® to Include Patient Selection for PSMA-Targeted Therapy
PR NewswireFirst Patient Dosed in Phase II 'CA-NINE' Trial of TLX250-CDx for Detection of Recurrent Kidney Cancer After Surgery
PR NewswireTelix to Acquire RLS to Expand North American Manufacturing and Distribution Platform
PR NewswireTelix to Acquire RLS to Expand North American Manufacturing and Distribution Platform
PR NewswireTelix Announces Cardinal Health as U.S. Commercial Distributor for Zircaix®
PR Newswire'Highly Accurate': Telix's Phase III ZIRCON Trial for Kidney Cancer Imaging Published in The Lancet Oncology
PR Newswire'Highly Accurate': Telix's Phase III ZIRCON Trial for Kidney Cancer Imaging Published in The Lancet Oncology
PR NewswireIPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances
Wer­bung

Telix Pharmaceuticals News

Telix Pharmaceuticals News: auf dieser Seite finden Sie alle Telix Pharmaceuticals News und Nachrichten zur Telix Pharmaceuticals Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Telix Pharmaceuticals News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Telix Pharmaceuticals News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.